Redcare Pharmacy: E-prescription growth accelerates
Reading Time: 2 minutes
Redcare Pharmacy N.V. has exceeded revenue expectations in the second quarter of 2024, releasing impressive preliminary and unaudited sales figures. Total revenue increased by 33% compared to the previous year, reaching 560 million euros, slightly surpassing the consensus expectation of 558 million euros. Revenue from over-the-counter products (Non-Rx) amounted to 390 million euros, reflecting a year-on-year increase of 21%. Particularly remarkable was the Rx revenue (prescription medications) in Germany, which rose by 37% to 50 million euros....
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
